Pharmacological chaperones for the misfolded melanocortin-4 receptor associated with human obesity

Hui Huang1, Wei Wang1, Ya-Xiong Tao1

  • 1Department of Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL 36849, United States.

Insights

Mutant melanocortin-4 receptors (MC4R) causing obesity can be rescued. This review explores methods to stabilize and target these misfolded proteins to the cell surface for potential therapeutic benefits.

Area of Science:

  • Biochemistry
  • Genetics
  • Pharmacology

Background:

  • The melanocortin-4 receptor (MC4R) is crucial for regulating energy balance.
  • MC4R mutations lead to early-onset severe obesity, with many mutants misfolded and retained intracellularly.
  • Some misfolded MC4R mutants may regain function if correctly targeted to the cell surface.

Purpose of the Study:

  • To review strategies for rescuing misfolded MC4R mutants.
  • To discuss the potential of chaperones in correcting MC4R protein folding defects.

Main Methods:

  • Review of literature on MC4R mutant rescue.
  • Analysis of chaperone-assisted protein stabilization and trafficking.
  • Evaluation of pharmacological chaperones like Ipsen 5i and Ipsen 17.

Main Results:

  • Misfolded MC4R mutants can be stabilized and trafficked to the plasma membrane by various chaperones.
  • Molecular and chemical chaperones show potential but have limitations like non-specific action and high dosage requirements.
  • Specific pharmacological chaperones, such as Ipsen 5i and Ipsen 17, demonstrate high potency and efficacy.

Conclusions:

  • Different approaches exist to rescue misfolded MC4R mutants.
  • Targeting MC4R misfolding presents a therapeutic avenue for obesity treatment.
  • Further research into effective chaperone strategies is warranted.

Related Concept Videos

Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
20.6K
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

15.3K
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
3.0K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.9K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
331
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
1.1K